Page 97 - Sohini Das

India to launch Covid-19 vaccine by August 15: ICMR chief Bhargava

ICMR and Hyderabad-based Bharat Biotech are jointly working on preclinical as well as clinical development of Covaxin

GI Council wants standard Covid treatment rates for easier claim settlement

Insurers will be guided by referral rates while processing hospitalisation claims. If actual charges exceed referral rates due to various medical exigencies, insurers will consider them while processi

KKR to acquire controlling stake in JB Chemicals for Rs 3,750 crore

The total deal size thus will be around $500 mn or around Rs 3,750 crore

More drugs may see price revisions as raw material costs, expenses rise

API prices have gone up by 25-30 per cent for some drugs in recent months

As cases rise, surge in bio-waste raises a fresh challenge in Covid fight

Used protective gear, masks, gloves and syringes add to environmental concerns as well as financial costs of hospitals

Policy flip-flops may puncture India's image as 'pharmacy of the world'

India supplies almost 20 per cent of the medicines consumed by the world. Every third tablet in the US market is from India

DRL to launch innovator brand of favipiravir, is silent on pricing

Ties up with Fujifilm for exclusive rights over Avigan for Indian market, can sell overseas too

China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Govt is trying to reduce dependence on China for APIs and develop indigenous sources

Relief for pharma firms as govt starts clearing API imports from China

This comes after a week of economic disruption caused by introducing stringent scrutiny, resulting in shipments originating in China getting held up at Indian ports.

Covid-19 crisis: Health care workers may get vaccine after phase 2 trials

Indigenously developed Bharat Biotech's vaccine candidate Covaxin is entering human trials on Wednesday.

Covid-19 crisis: Bharat Biotech's vaccine gets nod for human trials

The SARS-CoV-2 strain was isolated at National Institute of Virology (Pune), an institute under the ICMR, and transferred to Bharat Biotech.

Covid-19 crisis: Govt allows PPE exports after prices crash over 65%

Prices of some grades of PPE have crashed by over 65 per cent in the last one and a half months owing to glut in the domestic market.

Mumbai tweaks discharge protocol in bid to free tertiary care beds faster

City's top hospitals say average length of stay for a Covid-19 patient is now around seven days, down 50% from 14-days in the beginning of the pandemic

Sun Pharma to launch its first innovative product for psoriasis in Japan

Nod for Ilumya, a specialty product, would strengthen firm's dermatology portfolio in Japan, but analysts caution that the segment has been witnessing price erosion of late

Hindustan Antibiotics seeks redemption amid rising anti-China sentiments

The firm is charting a turnaround plan by beginning the manufacturing of key bulk drugs that the government has identified under a production-linked incentive (PLI) scheme

Dexamethasone and remdesivir included in Covid-19 treatment protocol

The Ministry of Health and Family Welfare (MoHFW) on Saturday released the updated clinical management protocol for managing Covid-19 cases

Piramal sells 20% in pharmaceutical business to Carlyle for $490 mn

Carlyle will pick up a 20 per cent stake for $490 million or around Rs 3,700 crore in the pharma subsidiary called Piramal Pharma Ltd

India's coronavirus drug market set for price war as firms ready launches

Sources say Cipla-BDR's favipiravir will be at least 30 per cent cheaper than Glenmark's price of Rs 103 per tablet. Cipla did not confirm.

Marico Foundation rewards innovators making a difference in Covid fight

Three products that offer innovative and affordable protective solutions have been selected

Govt mulls faster drug approval process, regulatory system overhaul

The industry, which has been lobbying for faster approvals for quite some time now, says the current pandemic should help expedite the reforms process